A team of researchers sought to identify the association between atrial fibrillation and breast cancer in women aged 66 years and older.
Researchers evaluated the link between hydroxychloroquine use and corrected QT length in patients with SLE and RA without cardiovascular disease.
Using an IV sotalol formulation, researchers were able to develop a safe and cost-effective option for administering the antiarrhythmic drug.
A study finds that dronedarone increased the risk for major bleeding events in patients with atrial fibrillation also taking a DOAC.
Researchers examined the 4-year outcomes of the PRAGUE-17 trial, which compared the effectiveness of LAA closure against NOACs for preventing cardioembolic events in AF.
Researchers conducted an evaluation to validate whether the Sieira risk score model was effective for predicting risk of sudden cardiac death in Brugada syndrome.
Researchers set out to determine if using 3D-upsampled data from 2D-LGE-CMR sequences would be superior to conventional 2D assessment for identifying transmural scarring in patients with VT.
Researchers sought to determine rates of GI bleeding among DOACs like apixaban, dabigatran, and rivaroxaban.
Researchers compared the modified Valsalva maneuver to the standard method to assess efficacy and safety for converting SVT to sinus rhythm.
Researchers sought to determine the associations between epigenetic age acceleration measures and incident AF.